Who is the CEO of Hexagon Nutrition Ltd?
- Answer Field
-
Arun Purushottam Kelkar is the Chairman and Director of Hexagon Nutrition Ltd.
Hexagon Nutrition Ltd. is a nutrition-focused company engaged in the development, manufacturing, and distribution of nutrition and wellness products. The Hexagon Nutrition IPO will open for subscription on June 5, 2026, and close on June 9, 2026. The IPO comprises 3,08,59,704 equity shares with a price band of ₹42 to ₹45 per share and a lot size of 333 shares.
Hexagon Nutrition Ltd. is a nutrition-focused company engaged in the research, development, manufacturing, and distribution of a range of nutrition products. Its portfolio includes micronutrient premixes, clinical and therapeutic nutrition products, branded wellness solutions, ready-to-use foods, and micronutrient powders. Through its distribution network and export operations, the company has established a presence across domestic and international markets. The company operates across various segments of the nutrition industry, including food fortification, wellness nutrition, clinical nutrition, and malnutrition management. Its products are distributed through pharmacies, hospitals, e-commerce platforms, online pharmacies, and institutional channels. With manufacturing capabilities, research infrastructure, and an international footprint, the company participates in both domestic and export markets. Its diversified product portfolio and integrated business model enable it to address nutritional requirements across different customer categories and geographies.
Investors can apply for the Hexagon Nutrition Ltd IPO through the ASBA (Application Supported by Blocked Amount) facility offered by banks or through their stockbroker's online trading platform. To submit an application, investors need an active PAN, Demat account, and trading account. During the IPO subscription period, applicants can log in to their preferred investment platform, select the Hexagon Nutrition Ltd IPO from the list of available public issues, enter the desired bid quantity, and confirm the application after reviewing the details. Once the application is submitted, the corresponding amount is blocked in the investor's bank account until the allotment process is completed. If shares are allotted, the amount is debited, and the shares are credited to the investor's Demat account. In case of non-allotment or partial allotment, the remaining blocked funds are released as per the applicable process. Investors should carefully review the Red Herring Prospectus and all relevant disclosures before making an investment decision.
For more details, visit the Hexagon Nutrition IPO page.
Details | Information |
IPO Date | June 5, 2026 to June 9, 2026 |
Issue Size | 3,08,59,704 shares (agg. up to ₹138.87 Cr) |
Price Band | ₹42 to ₹45 per share |
Lot Size | 333 shares |
Listing At | BSE, NSE |
Carry out the offer for sale of up to 30,859,704 equity shares
Achieve the benefits of listing the equity shares on the stock exchanges
Event | Date |
|---|---|
IPO Open Date | Fri, Jun 5, 2026 |
IPO Close Date | Tue, Jun 9, 2026 |
Tentative Allotment | Wed, Jun 10, 2026 |
Initiation of Refunds | Thu, Jun 11, 2026 |
Credit of Shares to Demat | Thu, Jun 11, 2026 |
Tentative Listing Date | Fri, Jun 12, 2026 |
Cut-off time for UPI mandate confirmation | 5 PM on Tue, Jun 9, 2026 |
₹42 to ₹45 per share
Application | Lots | Shares | Amount |
Retail (Min) | 1 | 333 | ₹14,985 |
Retail (Max) | 13 | 4,329 | ₹1,94,805 |
S-HNI (Min) | 14 | 4,662 | ₹2,09,790 |
S-HNI (Max) | 66 | 21,978 | ₹9,89,010 |
B-HNI (Min) | 67 | 22,311 | ₹10,03,995 |
The Hexagon Nutrition IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:
Access your trading account using the trading platform.
Go to the IPO section to view active IPO listings.
Locate Hexagon Nutrition IPO in the list of available IPOs and click the ‘Apply’ button.
Specify the number of shares (lot size: 333 shares) at the price band of ₹42 to ₹45 per share.
Enter your UPI ID for payment authorisation and ensure sufficient funds in your bank account.
Review your application details and confirm the UPI mandate before 5 PM on the last application day.
Submit the application and monitor the allotment status to check if shares have been allocated to you.
The allocation of shares in the Hexagon Nutrition IPO is structured across investor categories in line with applicable regulatory requirements. The issue provides defined reservations for qualified institutional buyers, non-institutional investors, and retail individual investors, with each category allotted a specified proportion of the net issue. This allocation framework outlines how the shares offered are distributed among different classes of investors.
Investor Category | Shares Offered |
Anchor Investors | 92,57,911 (30.00%) |
Non-Institutional Investor | 46,28,956 (15.00%) |
Qualified Institutional Buyers | 61,71,941 (20.00%) |
Retail Individual Investor | 1,08,00,896 (35.00%) |
Total Shares Offered | 3,08,59,704 (100.00%) |
This structure reflects the allocation approach as disclosed in the issue documents, indicating the proportion of shares available to each investor category.
Total Assets: Declined from ₹288.90 crore in FY23 to ₹261.36 crore as of March 2025.
Total Income: Recorded at ₹331.29 crore in March 2025, as compared to ₹281.65 crore in FY23.
Profit After Tax (PAT): Reported at ₹24.38 crore in March 2025, and ₹5.82 crore in FY23.
Net Worth: Recorded at ₹195.60 crore in March 2025 compared to ₹163.84 crore in FY23.
Reserves & Surplus: Stood at ₹183.89 crore in March 2025, as compared to ₹152.30 crore in FY23.
Total Borrowings: Stood at ₹26.60 crore in March 2025, as compared to ₹51.87 crore in FY23.
EBITDA: Stood at ₹40.07 crore in March 2025 in comparison to ₹17.17 crore in FY23.
The company reported growth in total income during the reviewed period across its nutrition and healthcare product segments.
Profitability improved over the period, indicating changes in earnings performance and operational efficiency.
The company’s net worth increased, reflecting the strengthening of its financial position through retained earnings and business operations.
Growth in reserves and surplus suggests an accumulation of earnings within the business, contributing to the company’s capital base.
The company reduced its overall borrowings, which may support a more balanced capital structure and lower dependence on external debt.
Operating earnings showed improvement during the period, reflecting developments in the company’s manufacturing, distribution, and product portfolio activities.
Total assets declined during the review period, while the company continued to operate across multiple nutrition categories and domestic as well as international markets.
The company’s focus on research and development, product diversification, and distribution capabilities may support future business expansion initiatives.
Demand trends related to nutrition, wellness, food fortification, and clinical nutrition continue to shape opportunities across the markets in which the company operates.
Its presence across consumer, institutional, and business segments provides exposure to multiple areas of the nutrition value chain, supporting business continuity and product development efforts.
The company operates in the nutrition and healthcare sector, where changes in regulations, quality standards, product approvals, and compliance requirements could affect business operations and product distribution.
A portion of the company's business is linked to domestic and international markets. Changes in demand patterns, raw material availability, supply chain disruptions, or economic conditions across key markets could influence business performance.
The company has a diversified portfolio spanning wellness nutrition, clinical nutrition, food fortification, micronutrient premixes, and ready-to-use nutrition products, providing exposure to multiple segments within the nutrition industry.
Growing awareness of nutrition, preventive healthcare, food fortification, and wellness products, combined with the company's research capabilities, distribution network, and international presence, may support future business expansion and product development initiatives.
Key Performance Indicator (KPI)
KPI | Dec 31, 2025 | Mar 31, 2025 |
ROE | 13.02% | 10.47% |
ROCE | 14.82% | 17.06% |
Debt/Equity | 0.18 | 0.14 |
RoNW | 12.12% | 12.46% |
PAT Margin | 9.81% | 7.36% |
EBITDA Margin | 14.03% | 12.33% |
Price to Book Value | 2.48 | 2.83 |
Registrar | Lead Manager(s) |
|---|---|
Kfin Technologies Ltd. | Cumulative Capital Pvt. Ltd., Catalyst Capital Partners Pvt. Ltd. |
404 Global Chamber,
Adarsh Nagar Link Road,
Andheri (W),
Mumbai, Maharashtra, 400053
Phone: +91 22 6213 6710
Email: cs.hnpl@hexagonnutrition.com
Website: https://hexagonnutrition.com/
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Hexagon Nutrition IPO allotment status.
Arun Purushottam Kelkar is the Chairman and Director of Hexagon Nutrition Ltd.
The Hexagon Nutrition IPO is scheduled to open for subscription on June 5, 2026, and will close on June 9, 2026. During this period, eligible investors can submit their applications through ASBA or supported online investment platforms.
Hexagon Nutrition Ltd. operates in the nutrition sector and is engaged in the research, development, manufacturing, and distribution of micronutrient premixes, wellness products, clinical nutrition products, therapeutic nutrition formulations, ready-to-use foods, and micronutrient powders. The company serves consumer, institutional, and business segments through domestic and international markets. Its business model is supported by manufacturing facilities, research and development capabilities, distribution networks, and a diversified product portfolio. However, the long-term sustainability of the business remains subject to factors such as market demand, regulatory developments, competition, raw material availability, and operational execution.
The Hexagon Nutrition IPO comprises 3,08,59,704 equity shares and has an aggregate issue size of up to ₹138.87 crore. The issue is structured entirely as an Offer for Sale (OFS), under which existing shareholders are offering shares for sale.
The ‘pre-apply’ facility allows investors to indicate their interest in an IPO before the subscription window opens. Through this feature, investors can submit application details in advance, and the application is processed when the IPO becomes available for subscription. The availability of this facility may vary across investment platforms.
The minimum lot size for the Hexagon Nutrition IPO is 333 equity shares. Retail investors applying for one lot are required to apply for at least 1 lot (333 shares) at the applicable issue price within the declared price band of ₹42 to ₹45 per share.
The tentative basis of allotment for the Hexagon Nutrition IPO is scheduled for June 10, 2026. The allotment process is carried out after the closure of the subscription period and in accordance with the applicable regulatory framework.
KFin Technologies Ltd. has been appointed as the registrar to the Hexagon Nutrition IPO. The registrar is responsible for managing the allotment process, investor records, refund-related activities, and allotment status queries associated with the public issue.
There are no publicly stated governance issues or red flags highlighted. Investors may review the offer documents, including sections on management, board composition, and risk factors, for detailed and verified disclosures.
Investors can apply for the IPO through the ASBA facility offered by banks or through a registered trading platform that supports IPO applications. The process generally involves logging into the trading account, selecting the IPO, entering the bid quantity, providing a UPI ID where applicable, authorising the payment mandate, and submitting the application before the closing date. Funds remain blocked until the allotment process is completed.
Yes, investors are generally required to have an active Demat account to apply for the Hexagon Nutrition IPO. In the event of share allotment, the allotted shares are credited electronically to the investor’s Demat account.
After the allotment process is completed, investors can check their allotment status through the registrar’s website using details such as PAN, application number, or Demat account information. If shares are allotted, they will be credited to the investor’s Demat account. In cases where shares are not allotted, the blocked application amount is released according to the applicable process.
Disclaimer :
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited
This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading